TelyRx Holdings Inc. is experiencing a significant drop in its stock price, raising concerns among investors.
TelyRx Holdings Inc. (TELY.TO) is facing a challenging trading session as its stock price has fallen by 5.26%, closing at CA$2.70. This downturn marks a troubling trend for the company, especially given its recent financial performance and market activities.
Investor takeaway: Investors should closely monitor TelyRx's financial health and market sentiment, as today's decline may signal deeper issues within the company.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$75.75M
52W high
$4.25
52W low
$2.00
1W change
+3.64%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 110.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+110.5% Upside
Current Price
C$2.85
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
93.1%
Annualized
90-Day Vol
95.8%
Annualized
Trend (90d)
-35.3%
Annualized drift
90d Mean
C$2.51
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.73 | C$1.98 – C$3.77 |
| 60 trading days | C$2.62 | C$1.66 – C$4.13 |
| 90 trading days | C$2.51 | C$1.44 – C$4.38 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
TelyRx Holdings Inc. sees a 5.26% drop in stock price today
This decline reflects ongoing investor concerns about the company's financial stability and future prospects.
Bull case
Despite today's drop, TelyRx has shown revenue growth in recent quarters. This suggests that there is potential for recovery if the company can stabilize its operations and manage losses effectively.
Bear case
The significant loss today raises red flags about TelyRx's ability to maintain investor confidence. This is particularly concerning given the company’s recent net losses and lack of positive news.
Today's Performance Overview
TelyRx Holdings Inc. is down 5.26% in today’s trading session, closing at CA$2.70. This decline follows a period of volatility for the stock, which has seen fluctuating investor sentiment. The market cap now stands at approximately CA$75.7 million, raising questions about the company's future in a competitive industry.
Financial Health Concerns
The recent financial results for TelyRx have not been encouraging. The company reported a net loss of CA$4.7 million for Q1 2026, an increase from previous quarters. With a profit margin of -18.17%, investors are likely worried about the company's ability to turn a profit in the near future. These financial challenges could be contributing to today's stock price decline.
Market Sentiment and Future Outlook
Investor sentiment appears to be shifting negatively as TelyRx's stock continues to face pressure. The lack of recent positive news, combined with the company's financial struggles, may lead to further declines unless significant changes are made. Investors should remain vigilant and consider the potential risks before making any decisions regarding TelyRx Holdings Inc.
Advertisement
Wealth Awesome Newsroom
The Wealth Awesome Newsroom delivers timely Canadian market updates, earnings, dividends, and stock movers for DIY investors. Coverage is reviewed against public filings and market data feeds.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
